re: fda approval Thats right, it opens up all sorts of questions. Remember that coramsine did show partial responses and a long term remission out of the 6 only patients that completed the full treatment . These were late stage refractory patients for whome there was no other treatment. Depends on interpretation I guess.
One of the responses was NSCLC, the biggest killer cancer in the USA
- Forums
- ASX - By Stock
- SBP
- re: fda approval
SBP
solbec pharmaceuticals limited
re: fda approval, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online